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In our case, AR was actually due to the sequelae of
endocarditis and not to structural valve degeneration. Tech-
nical issues for TAVI in patients with stentless bioprostheses
are different from those in patients with native aortic stenosis
or a stented bioprosthesis. Positioning may be more difficult
because of the absence of calcification, and the role of con-
comitant TEE should be emphasized. The absence of calci-
fication or stents may also theoretically increase the risk of
prosthesis migration because of potentially less stable an-
chorage on the aortic annulus. However, this report illus-
trates the feasibility of TAVI in patients with severe
dysfunction of a stentless bioprosthesis.
Valve-in-valve implantation may represent a promising
opportunity for the future,5 inasmuch as limited durability
is the major concern of stented or stentless bioprostheses.
Further studies including a large number of patients and lon-
ger follow-up are required to define the exact role of TAVI in
elderly patients with a degenerated bioprosthesis that
requires reintervention.
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FIGURE 2. Computed tomographic scan confirmed the good positioning of the CoreValve Revalving System.
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an alternative to surgical aortic valve replacement for the
treatment of patients with severe aortic stenosis considered
to be at very high or prohibitive surgical risk.1 In this report
we present, for the first time, a case of TAVI fully guided by
transesophageal echocardiography (TEE), with no angiogra-
phy, and we also discuss the usefulness of echocardiography
for guiding TAVI procedures.rgery c October 2009
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A 73-year-old woman with severe aortic stenosis was ad-
mitted to our hospital with a diagnosis of pulmonary edema.
She had a history of bypass grafting, stroke, peripheral vas-
cular disease, severe calcification of the ascending aorta, and
chronic renal failure. Doppler echocardiography showed
a mean aortic gradient of 33 mm Hg, an aortic valve area
of 0.65 cm2, and a left ventricular ejection fraction of
30%. Coronary angiography showed patency of all grafts.
The patient was refused for conventional surgical aortic
valve replacement (Society of Thoracic Surgeons score
14.5%) and she was then evaluated for transcatheter valve
implantation. Contrast-enhanced computed tomography
showed complete occlusion of both iliac arteries precluding
a retrograde approach through the femoral artery, and TAVI
was then proposed. The procedure was authorized by Health
Canada under compassionate special access.
The procedure was performed in the operating room by
a team of cardiac surgeons and interventional cardiologists us-
ing techniques extensively described in previous reports.2 On
the basis of an aortic annulus measurement of 20mm by TEE,
a 23-mm Edwards SAPIEN valve (Edwards Lifesciences Inc,
Irvine,Calif)was selected for implantation. Inour routineprac-
tice, a pigtail catheter is advancedup to the aortic valve to guide
valve positioning by angiography, but in this case iliac occlu-
sion precluded the femoral approach. Furthermore, there was
a radial thrombosis at the right side and left radial punctureThe Journal of Thoracic and Cawas associatedwith severe vasospasm precluding any catheter
advancement.Consequently,we then decided to guide the pro-
cedure by TEE exclusively. We took special care to appropri-
ately identify the aortic and ventricular ends of the stent
containing the valve at TEE (Figure 1, A). The valve was po-
sitioned with about half of the stent below and half above
the aortic annulus as determined by TEE. The hinge point of
the anterior mitral leaflet was also used as an anatomic marker
for positioning the ventricular end of the stent (Figure 1, B).
Valve deployment was performed under rapid pacing and, im-
portantly, the final position of the valve was verified again by
TEE during rapid pacing just before deployment (Figure 1, C
and D). TEE images after valve deployment showed the cor-
rect position of the valve, with its ventricular end located at
the hinge point of themitral valve (Figure 2,A). Doppler echo-
cardiography showed a mean residual aortic gradient and aor-
tic valve area of 4 mmHg and 1.32 cm2, respectively, and the
absenceof aortic regurgitation (Figure 2,B). The postoperative
period was uneventful and the patient was discharged 5 days
after the procedure. At 1-month follow-up, the patient was in
New York Heart Association functional class II and there
were no changes in the echocardiographic parameters.
DISCUSSION
The present case demonstrates the feasibility of guiding
a TAVI exclusively with TEE and represents one step further
on the role of TEE in TAVI procedures. The usefulness ofFIGURE 1. TEE images (long-axis view) during transapical aortic valve implantation. A, Transcatheter valve in the left ventricular cavity before deployment
showing the ventricular and aortic ends of the stent containing the valve (white arrows). B, Accurate positioning of the valve using the hinge point of the
anterior mitral leaflet (thin white arrow) as a marker for the ventricular end of the valve (thick white arrow). C, Verification of the position of the valve (thick
white arrows) under rapid pacing (thin white arrow) just before deployment. D, Valve deployment by balloon inflation (thick white arrow) under rapid pacing
(thin white arrow).rdiovascular Surgery c Volume 138, Number 4 1023
Brief Technique ReportsFIGURE 2. TEE images (long-axis view) after valve implantation showing the adequate position of the transcatheter valve, with the ventricular end of the
stent containing the valve (white arrow) at the level of the hinge point of the mitral valve (A) and the absence of paravalvular aortic regurgitation (B).echocardiography in TAVI has been outlined in previous
studies,3,4 but very little data exist on the role of TEE during
a key point of the TAVI procedure such as valve positioning
and deployment. In fact, an error during valve positioning can
be associated with a life-threatening complication such as
valve malposition or embolization.5 Up to now, angiography
has been the gold standard for valve positioning and
deployment. However, obtaining an adequate angiographic
view of the aortic valve can be difficult and usually requires
several contrast injections with the subsequent increased
risk of contrast-induced nephropathy. Also, deciding the final
position of the transcatheter valve on the basis of angiographic
images might be challenging and, again, usually necessitates
several contrast injections. As has been shown in the present
report, TEE can provide very accurate images of the transcath-
eter valve before deployment (Figure 1). Also, TEE allows the
use of other anatomic markers such as the mitral valve, which
probably makes TEE a more reliable and reproducible tech-
nique for valve positioning. However, in some instances the
echocardiographic images do not allow a clear differentiation
between the stent containing the valve and the balloon on
which the stent has been crimped. This may be partially
related to the lack of coaxiality of the valve–balloon system,
especially in those cases in which the transfemoral approach1024 The Journal of Thoracic and Cardiovascular Sis used. Also, extremely severe calcification of the aortic valve
and annulus may somewhat reduce the quality of echocardio-
graphic visualization of the prosthetic valve, which may limit
the performance of TEE for the guidance of valve positioning.
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